Detalhe da pesquisa
1.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Am J Gastroenterol
; 118(7): 1237-1247, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36716287
2.
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Aliment Pharmacol Ther
; 58(1): 60-70, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37089065